639858-32-5

639858-32-5 structure

Name: BMS 605541
Chemical Name: N-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide
CAS Number: 639858-32-5
Molecular Formula: C₁₉H₁₇F₂N₅OS
Molecular Weight: 401.433
Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK PDGFR
Create Date: 2021-01-16 09:42:07
Modify Date: 2024-01-20 11:10:40
BMS-605541 is a selective and orally active inhibitor of VEGFR-2 kinase with an IC50 value of 23 nM and Ki value of 49 nM. BMS-605541 inhibits the activity of Flk-1, VEGFR-1 and PDGFR-β with IC50 values of 40 nM, 400 nM and 200 nM, respectively. BMS-605541 can be used for cancer research[1].

Name	N-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide
Synonyms	N-Cyclopropyl-2,4-difluoro-5-({[2-(2-pyridinylamino)-1,3-thiazol-5-yl]methyl}amino)benzamide N-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide N-cyclopropyl-2,4-difluoro-5-({[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]methyl}amino)benzamide Benzamide, N-cyclopropyl-2,4-difluoro-5-[[[2-(2-pyridinylamino)-5-thiazolyl]methyl]amino]-

Description	BMS-605541 is a selective and orally active inhibitor of VEGFR-2 kinase with an IC50 value of 23 nM and Ki value of 49 nM. BMS-605541 inhibits the activity of Flk-1, VEGFR-1 and PDGFR-β with IC50 values of 40 nM, 400 nM and 200 nM, respectively. BMS-605541 can be used for cancer research[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> PDGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> VEGFR
Target	VEGFR-2:23 nM (IC50) VEGFR-2:49 nM (Ki) Flk-1:40 nM (IC50) VEGFR-1:400 nM (IC50) PDGFR-β:200 nM (IC50)
In Vitro	BMS-605541 (Compound 14) 通过 VEGF 抑制 HUVECs 的生长，IC50 值为 25 nM[1]。
In Vivo	BMS-605541 (12.5-180 mg/kg；一天 1 次或一天 2 次，持续 14 天) 对皮下植入 L2987 和 HCT-116 异种移植物的无胸腺小鼠具有抗肿瘤活性[1]。 BMS-605541 的药代动力学 (PK) 参数[1] Species Administration manner Dose (mg/kg) Cmax (µM) Tmax (h) AUC (µM•h) T1/2 (h) MRT (h) Cl (mL/min•kg) Vss (L/kg) Fpo (%) Mouse Oral gavage 90 148 0.5 649 (0-24 h) 1.7 3.4 100 Mouse Intravenous injection 10 11.8 1.7 100 Rat Oral gavage 50 44.0 2.0 202 2.2 3.5 100 Rat Intravenous injection 10 13.6 1.1 100 Cyno Oral gavage 5 8.0 0.75 28.5 7.1 7.9 52 Cyno Intravenous injection 1 3.9 1.6 52
References	[1]. Borzilleri RM, et al. Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2. J Med Chem. 2006 Jun 29;49(13):3766-9.

Density	1.4±0.1 g/cm3
Molecular Formula	C₁₉H₁₇F₂N₅OS
Molecular Weight	401.433
Exact Mass	401.112183
LogP	1.95
Index of Refraction	1.660

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

639858-32-5	1549811-36-0
1675201-90-7	543730-41-2
1174046-72-0	918348-67-1
1059734-66-5	2691796-83-3
1272353-82-8	290315-45-6
1899086-88-4	1899059-97-2
1899054-58-0	1897050-56-4
1806546-90-6	1805525-72-7
1513681-37-2	1513681-65-6
1513681-71-4	1513681-69-0